anmelden
FTSE All-Share
5.563,81
PKT
+23,96
PKT
+0,43
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.07.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 29.07.16 | Diageo overweight | JP Morgan Chase & Co. | |
| 29.07.16 | BT Group overweight | JP Morgan Chase & Co. | |
| 29.07.16 | Barclays Hold | S&P Capital IQ | |
| 29.07.16 | AstraZeneca buy | Deutsche Bank AG | |
| 29.07.16 | BAT buy | Deutsche Bank AG | |
| 29.07.16 | BAT overweight | JP Morgan Chase & Co. | |
| 29.07.16 | BT Group Sell | Deutsche Bank AG | |
| 29.07.16 | Diageo Hold | Deutsche Bank AG | |
| 29.07.16 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 29.07.16 | Diageo Outperform | BNP PARIBAS | |
| 29.07.16 | Lloyds Banking Group overweight | Morgan Stanley | |
| 29.07.16 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 29.07.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.07.16 | Shell (ex Royal Dutch Shell) Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.07.16 | Diageo Neutral | Goldman Sachs Group Inc. | |
| 29.07.16 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 29.07.16 | BAT Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.07.16 | BT Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.07.16 | AstraZeneca neutral | Bernstein Research | |
| 29.07.16 | Lloyds Banking Group buy | UBS AG | |
| 29.07.16 | BAT Hold | Société Générale Group S.A. (SG) | |
| 29.07.16 | Diageo buy | S&P Capital IQ | |
| 29.07.16 | BT Group Hold | S&P Capital IQ | |
| 29.07.16 | BAT Hold | S&P Capital IQ | |
| 29.07.16 | Shell (ex Royal Dutch Shell) Hold | S&P Capital IQ | |
| 28.07.16 | GSK neutral | Bernstein Research | |
| 28.07.16 | HSBC buy | Citigroup Corp. | |
| 28.07.16 | Barclays Sell | Citigroup Corp. | |
| 28.07.16 | Lloyds Banking Group Sell | Citigroup Corp. | |
| 28.07.16 | GSK buy | Goldman Sachs Group Inc. | |
| 28.07.16 | GSK Neutral | UBS AG | |
| 28.07.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.07.16 | GSK Hold | S&P Capital IQ | |
| 27.07.16 | BP buy | Citigroup Corp. | |
| 27.07.16 | AstraZeneca buy | Citigroup Corp. | |
| 27.07.16 | GSK buy | Citigroup Corp. | |
| 27.07.16 | Vodafone Group neutral | Independent Research GmbH | |
| 27.07.16 | BP buy | Société Générale Group S.A. (SG) | |
| 27.07.16 | BT Group Conviction Buy List | Goldman Sachs Group Inc. |